Skip to main content
Equibles
BLGO logo

BLGO · Biolargo, Inc.

Track BLGO — free

Use BLGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BLGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.09 0.00 (-0.22%) At close · Sep 17
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The foregoing factors raise substantial doubt about our ability to continue as a going concern, unless we are able to increase revenues, generate cash from operations, and/or generate cash from financing activities.”
View the 10-Q filed Aug 14, 2026
Market Cap
$29.59M
Shares
328.73M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.09 Open$0.09 Day$0.09–0.10 52W close$0.08–0.22 Avg vol 30d414K Short int9K · 0.0% float · 1.0d Short vol64% DataJan 2020–Sep 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$4.08M
Trailing 12 months
Net income (TTM)
−$18.79M
Trailing 12 months
Revenue growth YoY
-55.1%
Year over year
Operating margin
-444.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.4%
Year over year · more shares
Price change (1Y)
-60.7%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −37%
below
Price vs 50-day avg −13%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 5%
near low
Momentum
relative strength
Very Weak
1-month return −5%
trailing
6-month return −44%
trailing
YTD return −50%
this year
Relative strength −62%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -61.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Squeeze score 20
low risk · 0–100
Fundamentals
Strong
Revenue growth +4251%
Y/Y
Gross margin 28%
contracting
Free cash flow $-8.3M
Balance sheet $3.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 91%
annualized · 1-yr
Max drawdown −62%
past year
ATR 10.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−37% Bearish
Price vs 50-day avg
−13% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -61.9% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 5% Range high $0
vs 200-day avg -37% vs 50-day avg -13%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BLGO
Biolargo, Inc.
this stock
$29.59M -49.9% -56.3% — 0.0%
LIN
Linde PLC
 $214.08B +7.5% +3.0% 30.0 1.2%
AIQUF
L Air Liquide SA /Fi
 $122.45B +0.4% — — 0.0%
SHW
Sherwin Williams Co
 $78.25B -1.0% +2.1% 29.7 2.9%
ECL
Ecolab Inc.
 $76.94B +3.5% +2.2% 36.8 1.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
1
% held
0.0%
Net QoQ
0 sh
Top holder
FIRST AMERICAN TRUST, FSB
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
8.9K
Days to cover
1.0d
Change
-14.5K sh
View
Short Volume
Short vol %
64%
As of
Sep 17, 2026
Short Total
View
Fails to Deliver
FTD shares
65
Value
$7
As of
Aug 20, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Aug 10, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$12.2M
Net income (FY)
$-3.7M
View
Filings
SEC Filings
Latest
8-K/A
Filed
Sep 14, 2026
This year
10
View
Exempt Offerings
Offering
$815.0K
Filed
Jan 23, 2024
View

Performance

5D 20D 120D MTD YTD
BLGO -9.8% -5.4% -43.6% -8.0% -49.9%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY -10.4% -4.5% -61.8% -7.4% -61.7%
Key facts CIK 880242 CUSIP 09065A100 Visit website Investor relations